Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2014 Mar 24;23(7):773–777. doi: 10.1002/pds.3615

Table 3. Baseline Characteristics Associated with Adverse Experiences.

Month 1 Score*
N=196
Point Estimate (95% CI)
Month 6 Score§
N=157
Point Estimate (95% CI)
Change in Score
N=157
Point Estimate (95% CI)
Weight (per 10kg) -1.8 (-3.0 to -0.6) -0.8 (-1.4 to -0.2) 0.9 (-0.5 to 02.2)
MM score 1.59 (0.68 to 2.50) 0.44 (-0.02 to 0.91) -1.08 (-2.07 to -0.09)
AUDIT score -0.35 (-0.61 to -0.09) 0.03 (-0.11 to 0.17) 0.46 (0.16 to 0.76)
CD4<100 -- -- -5.10 (-8.86 to -1.34)
*

adjusted R2: 0.111

§

adjusted R2: 0.047

adjusted R2: 0.109

The point estimate for weight reflects the associated change associated with a 10kg increase in baseline weight. Point estimates for other variables reflect the change associated with an increase of 1 unit.